Current Cardiology Reports最新文献

Intramural Ventricular Arrhythmias: How to Crack a Hard Nut. 室内室性心律失常：如何破解坚硬的坚果

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-27 DOI: 10.1007/s11886-024-02143-1

Matthew Hanson, Andres Enriquez, Fermin Garcia

{"title":"Intramural Ventricular Arrhythmias: How to Crack a Hard Nut.","authors":"Matthew Hanson, Andres Enriquez, Fermin Garcia","doi":"10.1007/s11886-024-02143-1","DOIUrl":"https://doi.org/10.1007/s11886-024-02143-1","url":null,"abstract":"Purpose of the review: Successful catheter ablation of ventricular arrhythmias depends on identifying the critical tissues that sustain the arrhythmia. Increasingly, the intramural space is being recognized as an important source of idiopathic and reentrant ventricular arrhythmias, representing a common cause of ablation failure. A systematic approach to mapping and ablating these arrhythmias is key to optimize outcomes.Recent findings: Intramural ventricular arrhythmias are common in certain anatomical locations such as the left ventricular ostium or the interventricular septum. In these cases, mapping of the septal coronary veins provides an opportunity to explore the intramural compartment of the septum to perform activation mapping, entrainment and/or pace mapping. When an intramural arrhythmia is identified, ablation may require radiofrequency application from multiple sites, prolonged lesions, or special ablation techniques such as bipolar ablation or transvenous ethanol injection. Identification of intramural ventricular arrhythmias depends on comprehensive mapping that should include the coronary venous system, and ablation often requires advanced techniques. This paper provides a guide on when to suspect an intramural ventricular arrhythmia in the electrophysiology laboratory and how to approach mapping and ablation in these challenging cases.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Echocardiography for Management of Cardiovascular Disease in Pregnancy. 超声心动图治疗妊娠期心血管疾病。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-09-26 DOI: 10.1007/s11886-024-02126-2

Mary Rodriguez Ziccardi, Joan E Briller

引用次数: 0

Echocardiography in Systemic Lupus Erythematosus. 系统性红斑狼疮的超声心动图。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-26 DOI: 10.1007/s11886-024-02121-7

Mohammed Z Al-Zahir, Kwan-Leung Chan

{"title":"Echocardiography in Systemic Lupus Erythematosus.","authors":"Mohammed Z Al-Zahir, Kwan-Leung Chan","doi":"10.1007/s11886-024-02121-7","DOIUrl":"10.1007/s11886-024-02121-7","url":null,"abstract":"Purpose of review: In patients with systemic lupus erythematosus (SLE), cardiovascular involvement is common and a major cause of morbidity and mortality. There have been few recent updates regarding the cardiac involvement in this clinical entity. The purpose of the review is to provide an update on the role of echocardiography in the management of these patients.Recent findings: Echocardiography remains the imaging modality of choice and should be considered even in asymptomatic patients with SLE to detect cardiac abnormalities which are frequently not clinically apparent. Transesophageal echocardiography has higher sensitivity and specificity in identifying valvular lesions, and should be utilized in high risk patients when transthoracic echocardiography is negative. New advances such as speckle tracking echocardiography has shown promise in the detection of occult myocardial dysfunction, but more studies are needed to have a proper perspective of its role in SLE patients. SLE has protean cardiac manifestations. The most common involvement is pericarditis. Complicated pericarditis such as tamponade and constriction are rare but should be considered if the symptoms do not subside with treatment. Valvular involvement can take several forms. Libman-Sacks endocarditis is the most common form and is more prevalent in patients with high disease activity and with the presence of antisphopholipid antibodies. Myocardial involvement portends poor prognosis and should be sought and treated promptly to prevent morbidity and mortality.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1265-1271"},"PeriodicalIF":3.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Promise and Perils of Transcatheter Aortic Valve Replacement (TAVR) in Low Surgical Risk Patients with Severe Aortic Stenosis in the Current Era. 经导管主动脉瓣置换术 (TAVR) 在当前时代对手术风险低的重度主动脉瓣狭窄患者的承诺与危险。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-16 DOI: 10.1007/s11886-024-02116-4

Ahmed Hassanin, Molly Szerlip

引用次数: 0

Chronic Venous Insufficiency Evaluation and Medical Management. 慢性静脉功能不全评估和医疗管理。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-31 DOI: 10.1007/s11886-024-02119-1

Suman Wasan

引用次数: 0

Lymphatic System Development and Function. 淋巴系统的发育和功能

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-22 DOI: 10.1007/s11886-024-02120-8

Harish P Janardhan, Brianna T Wachter, Chinmay M Trivedi

{"title":"Lymphatic System Development and Function.","authors":"Harish P Janardhan, Brianna T Wachter, Chinmay M Trivedi","doi":"10.1007/s11886-024-02120-8","DOIUrl":"10.1007/s11886-024-02120-8","url":null,"abstract":"Purpose of review: This review delves into recent advancements in understanding generalized and organ-specific lymphatic development. It emphasizes the distinct characteristics and critical anomalies that can impair lymphatic function. By exploring developmental mechanisms, the review seeks to illuminate the profound impact of lymphatic malformations on overall health and disease progression.Recent findings: The introduction of genome sequencing, single-cell transcriptomic analysis, and advanced imaging technologies has significantly enhanced our ability to identify and characterize developmental defects within the lymphatic system. As a result, a wide range of lymphatic anomalies have been uncovered, spanning from congenital abnormalities present at birth to conditions that can become life-threatening in adulthood. Additionally, recent research highlights the heterogeneity of lymphatics, revealing organ-specific developmental pathways, unique molecular markers, and specialized physiological functions specific to each organ. A deeper understanding of the unique characteristics of lymphatic cell populations in an organ-specific context is essential for guiding future research into lymphatic disease processes. An integrated approach to translational research could revolutionize personalized medicine, where treatments are precisely tailored to individual lymphatic profiles, enhancing effectiveness and minimizing side effects.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1209-1219"},"PeriodicalIF":3.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes. 肥胖作为 2 型糖尿病患者心脏病风险因素的作用。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-09-05 DOI: 10.1007/s11886-024-02129-z

Sushant Koirala, Michael Sunnaa, Thomas Bernier, Ahmet Afsin Oktay

{"title":"The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes.","authors":"Sushant Koirala, Michael Sunnaa, Thomas Bernier, Ahmet Afsin Oktay","doi":"10.1007/s11886-024-02129-z","DOIUrl":"10.1007/s11886-024-02129-z","url":null,"abstract":"Purpose of review: Cardiovascular disease (CVD) is the leading cause of death globally and is closely associated with obesity and type 2 diabetes mellitus (T2DM). This review examines the interplay between obesity, T2DM, and CVD, highlighting the increasing prevalence and economic burden of these conditions.Recent findings: Pharmacologic therapies, particularly glucagon-like peptide-1 receptor agonists, show promise in substantial weight loss and subsequent reduction of adverse cardiovascular events in obese individuals with and without diabetes. Obesity significantly contributes to the development of insulin resistance and T2DM, further escalating CVD risk. The common co-occurrence of these three conditions may involve several other pathophysiological mechanisms, such as chronic inflammation, increased visceral adiposity, and endothelial dysfunction. Until recently, lifestyle modifications and bariatric surgery had been the primary methods for weight loss and mitigating obesity-associated cardiovascular risk. Newer pharmacological options have led to a paradigm shift in our approach to obesity management as they provide substantial benefits in weight loss, glycemic control, and cardiovascular risk reduction.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1309-1320"},"PeriodicalIF":3.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Recent Advances in Positron Emission Tomography Radiotracers to Image Cardiac Amyloidosis. 用于心脏淀粉样变性成像的正电子发射断层扫描放射性同位素的最新进展。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-13 DOI: 10.1007/s11886-024-02114-6

Ardel J Romero Pabón, Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, Sharmila Dorbala

引用次数: 0

Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults. 应对美国黑人成年人中不成比例的顽固性高血压负担。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-09-05 DOI: 10.1007/s11886-024-02115-5

Tina K Reddy, Samar A Nasser, Anuhya V Pulapaka, Constance M Gistand, Keith C Ferdinand

{"title":"Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults.","authors":"Tina K Reddy, Samar A Nasser, Anuhya V Pulapaka, Constance M Gistand, Keith C Ferdinand","doi":"10.1007/s11886-024-02115-5","DOIUrl":"10.1007/s11886-024-02115-5","url":null,"abstract":"Purpose of review: Elevated blood pressure is the leading modifiable risk factor for cardiovascular morbidity and mortality in the US. Older individuals, Black adults, and those with comorbidities such as chronic kidney disease, have higher levels of uncontrolled and resistant hypertension. This review focuses on resistant hypertension, specifically in the US Black population, including potential benefits and limitations of current and investigational agents to address the disparate toll.Recent findings: There is a necessity to implement public health measures, including early screening, detection, and evidence-based hypertension treatment with lifestyle, approved and investigational agents. The evidence highlights the importance of implementing feasible and cost-effective public health measures to advocate for early screening, detection, and appropriate treatment of hypertension. A team-based approach involving physicians, advanced practice nurses, physician assistants, pharmacists, social workers, and clinic staff to implement proven approaches and the delivery of care within trusted community settings may mitigate existing disparities.","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":" ","pages":"1163-1171"},"PeriodicalIF":3.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Healthy Lifestyle and Cardiac Rehabilitation for Weight Loss. 减肥的健康生活方式和心脏康复。

IF 3.1 3区医学

Current Cardiology Reports Pub Date : 2024-11-01 Epub Date: 2024-09-04 DOI: 10.1007/s11886-024-02130-6

Christoph Höchsmann, James L Dorling, Carl J Lavie, Peter T Katzmarzyk

引用次数: 0